GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings. However, over the past few years, these medications have become popular due to ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

Among the studies we’ve selected is one on the much-debated link between eggs and cholesterol, how GLP-1 drugs can affect ... while discussing the potential mechanisms with a researcher.

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...

11 These mechanisms will be important to more fully elucidate to inform whether targeting central or peripheral GLP-1 receptors is necessary and thus whether higher CNS drug concentrations are needed.

The researchers fed both male and female mice food containing 0.15% aspartame daily — the equivalent of a person drinking three cans (or about 1 litre) of diet soda a day — for 12 weeks.

It's possible that the rapid correction of high blood sugar induced by GLP-1 drugs rather than a toxic effect "could be a possible mechanism for vision loss," the 2025 study noted. NAION is a very ...

These are some of the trends in weight management retailers and manufacturers are keeping an eye on in the new year to help ...

BIRMINGHAM, Ala. (WBRC) - Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become popular when used as a weight loss drug. But, ...

We independently screened all abstracts for eligibility, which consisted of studies reporting the effects of GLP-1RA administration ... 3 albiglutide, and 1 lixisenatide); of those, 7 articles ...